MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression (2016)
Fonte: OncoTarget. Unidade: FO
Assuntos: CARCINOMA, GENITÁLIA FEMININA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIA, Beatriz de Melo et al. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. OncoTarget, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.10247. Acesso em: 25 ago. 2024.APA
Maia, B. de M., Rodrigues, I. S., Akagi, E. M., Amaral, N. S. do, Ling, H., Monroig, P., et al. (2016). MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. OncoTarget. doi:10.18632/oncotarget.10247NLM
Maia B de M, Rodrigues IS, Akagi EM, Amaral NS do, Ling H, Monroig P, Soares FA, Calin GA, Rocha RM. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression [Internet]. OncoTarget. 2016 ;[citado 2024 ago. 25 ] Available from: https://doi.org/10.18632/oncotarget.10247Vancouver
Maia B de M, Rodrigues IS, Akagi EM, Amaral NS do, Ling H, Monroig P, Soares FA, Calin GA, Rocha RM. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression [Internet]. OncoTarget. 2016 ;[citado 2024 ago. 25 ] Available from: https://doi.org/10.18632/oncotarget.10247